Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302470 · ClinicalTrials.gov registry record · NA
Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01302470 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 30 participants.
The verdict
NCT01302470, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The primary goal of this study is to evaluate the use of robotically -assisted device leads as a primary strategy for heart resynchronization.This trials aims to compare transvenous lead placement with robotic lead placement for cardiac resynchronization therapy.
Interventions
- PROCEDURE Primary epicardial placement of left ventricular lead
- PROCEDURE Transvenous placement of left ventricular lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-02 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302470
The ClinicalTrials.gov registry entry for NCT01302470 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Primary epicardial placement of left ventricular lead is the first listed.
NCT01302470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302470 about?
NCT01302470 is a clinical study titled "Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy". The primary goal of this study is to evaluate the use of robotically -assisted device leads as a primary strategy for heart resynchronization.This trials aims to compare transvenous lead placement with robotic lead placement for cardiac resynchronization therapy.
What is the current status of trial NCT01302470?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01302470?
The interventions under investigation include: Primary epicardial placement of left ventricular lead (PROCEDURE), Transvenous placement of left ventricular lead (PROCEDURE).
Who is sponsoring clinical trial NCT01302470?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.